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jou r nal h o mep age: w ww.els evier . co m/lo c ate /ys eizWhile epidemiological studies do not indicate any differences
in the incidence of epilepsy in males and females, there may be
signiﬁcant differences in the impact and effect the condition may
have between males and females across all ages. Epilepsy is a
condition that can affect each person differently than the next.
Gender can be a factor in how epilepsy will affect the particular
person. Care also needs to consider gender-related differences in
epilepsy, other health considerations, hormonal changes, and
social function. In many ways, epilepsy is different for a woman
than a man. The differences arise because of biological differences
between women and men, and also because of the different social
roles of each gender. These differences may not only be due to
possible differences in antiepileptic drug (AED) efﬁcacy, AED drug-
drug interactions due to hormonal differences, and possible
teratogenic effects in women of child bearing age, but also
differences in the social impact of the condition.
After a ﬁrst Symposium on Gender Issues in Epilepsy seven
years ago, researchers and clinicians have become increasingly
aware that epilepsy has different implications for life and well-
being in men and women due to complex interactions between
antiepileptic drugs, endocrine function and the epilepsy itself (all
papers from the ﬁrst Gender Issues in Epilepsy Meeting published
in Seizure, 2008; 17: 99–209). Moreover, the fact that epilepsy not
only affects the patient but also the family due to teratogenic
effects of antiepileptic drugs, psychiatric comorbidity and socio-
economic challenges are reaching physicians and the patient
community. There is now also an increased understanding of
gender differences in the epidemiology of epilepsy and of speciﬁc
epilepsy syndromes. Various published studies indicate that
females have a marginally lower incidence of epilepsy and
unprovoked seizures than males. Although reviews of this gender
topic often focus on pregnancy-related issues for women with
epilepsy, speciﬁc health concerns for women and men with
epilepsy are present throughout all phases of reproductive life.
Epilepsy and antiepileptic drug treatment affect sexual develop-
ment, menstrual cycle, aspects of contraception, fertility and
reproduction.
The second Symposium on Gender Issues in Epilepsy was held
on August 28th–29th 2014 again in Oslo, Norway. The goals of thishttp://dx.doi.org/10.1016/j.seizure.2015.02.001
1059-1311/ 2015 Published by Elsevier Ltd on behalf of British Epilepsy Association.meeting were to highlight the available evidence as well as the lack
of data for the clinical care of epilepsy patients. Gender issues and
the reciprocal relationship between epilepsy and female and male
physiology, sexuality and fertility in different stages of life have
been discussed for women and men with epilepsy. The symposium
was designed to encourage discussion, interest and further future
research in this rapidly growing ﬁeld of epilepsy.
This special issue of Seizure provides reviews and late breaking
news on various topics in the diagnosis and management of
epilepsy patients in reproductive age and face a unique set of both
female and male reproductive issues, ranging from descriptions of
disorders of reproduction in epilepsy and its causes, to catamenial
epilepsy, to contraception, and to the many aspects of epilepsy and
pregnancy.
Epilepsy affects sexual development, menstrual cycle, can
inﬂuence choice of contraception, and may affect pregnancy
outcomes. These factors will have an impact of the choice of an AED
in patients with epilepsy, due to differences in the efﬁcacy and
safety of each drug, and also on the patient’s acceptability of the
drug.
As has been seen from this gender issue meeting, differing
effects of sex hormones can lead to signiﬁcant differences between
men and women in prognosis, treatment and social impact of
persons with epilepsy. These differences could range from the
incidence of various types of seizures, decreased birth rates in
females, pregnancy-related complications, and social impact and
quality of life. Gender also has an impact on the treatment of
epilepsy, selection of antiepileptic drugs and incidence of co-
morbidities.
The information on the comparative teratogenicity of AEDs in
humans is still conﬂicting, mainly due to inadequate sample size
and methodological differences between previous studies. The
teratogenic potential of newer AEDs is even less known, a situation
that prevents a rational approach to AED treatment in women of
childbearing potential. Obstetrical complications, the impact of
seizures on pregnancy and delivery, psychological implications of
pregnancy in epilepsy, the children exposed to antiepileptic drugs
in utero – effect, different malformations in offspring of women
with epilepsy and breastfeeding have been discussed at this
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and antiepileptic drugs, changes in seizure frequency with
hormonal contraception and the choose of contraceptional
methods for people with epilepsy. Sex differences in cognition
in epilepsy patients and does antiepileptic drugs result in cognitive
decline were also a theme at this meeting.
The Editor’s aim is to offer a thorough assessment of the current
state of reproductive and sexual disorders based on the indepen-
dent understanding of experts gained through practice, research,
and literature review. Therefore, this is not a consensus document.
However, despite some diversity of opinions, there is apparently
unanimous agreement on such important aspects of epilepsy and
hormonal changes.
This issue of Seizure provides the reader with current evidence
about a spectrum of clinically relevant topics in epilepsy. Clinical
care requires that we take these imperfect data and apply them to
individual patients. Understanding the limits and controversies
that surround these data can assist clinicians as well as their
patients and family members about clinical decisions that
inﬂuence care.To date, however, the focus on gender issues in epilepsy has
been mostly on females, with few studies being carried out in
males. Indeed, guidelines for the management of women with
epilepsy have been available for many years. Yet, despite these
guidelines, studies have indicated that their implementation needs
to be improved, with much more information being given to
patients in an interdisciplinary care approach. A third Gender
issues Meeting is already to be planed.
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